A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

The company said the weight loss was not accompanied by muscle density changes ... SKNY-1 dose-dependently reduced the behavior—high-dose animals ate less than healthy controls. The drug also made the ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

With more than 600 million Chinese adults projected to be overweight by 2050, the emergence of a viable local alternative to Novo and Lilly’s blockbuster GLP-1 treatments could make weight loss drugs ...

Grey market grows for cheap weight-loss drugs imported from China Some users try small doses of substances not yet approved ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

Renowned endocrinologist and diabetologist Dr Ambrish Mithal told IndiaToday.in talked about muscle loss after consuming ...

Some weight-loss drugs are being sold directly to consumers, bypassing insurance. Catholic devotees were stunned when an ...